Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec 24;56(24):11718-26.
doi: 10.1021/jf803298z.

In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent

Affiliations

In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent

Sharla L Powell et al. J Agric Food Chem. .

Abstract

Cimicifuga racemosa (L.) Nutt. (syn. Actaea racemosa L., black cohosh) is used to relieve menopausal hot flashes, although clinical studies have provided conflicting data, and the active constituent(s) and mechanism(s) of action remain unknown. Because serotonergic receptors and transporters are involved with thermoregulation, black cohosh and its phytoconstituents were evaluated for serotonergic activity using 5-HT7 receptor binding, cAMP induction, and serotonin selective re-uptake inhibitor (SSRI) assays. Crude extracts displayed 5-HT7 receptor binding activity and induced cAMP production. Fractionation of the methanol extract led to isolation of phenolic acids and identification of N(omega)-methylserotonin by LC-MS/MS. Cimicifuga triterpenoids and phenolic acids bound weakly to the 5-HT7 receptor with no cAMP or SSRI activity. In contrast, N(omega)-methylserotonin showed 5-HT7 receptor binding (IC50 = 23 pM), induced cAMP (EC50 = 22 nM), and blocked serotonin re-uptake (IC50 = 490 nM). These data suggest N(omega)-methylserotonin may be responsible for the serotonergic activity of black cohosh.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key phytoconstituents of black cohosh.
Figure 2
Figure 2. Bioassay guided fractionation scheme
The isolation scheme following the fractionation and subfractionation of the crude MeOH extract. The clinical extract (75% EtOH) had an IC50 of 55 μg/mL. The structures of the most relevant triterpenes, phenolic acids, and Nω-methylserotonin are shown in Figure 1.
Figure 3
Figure 3. Black cohosh induces intracellular cAMP
Dose-dependent induction of cyclic AMP (pmol/mL) for the clinical black cohosh extract (■) and XAD-MeOH extract, EC50 70 μg/mL (□) mediated through the 5-HT7 receptor.
Figure 4
Figure 4. Positive ion electrospray LC-MS analysis and tandem mass spectra of fraction 7 and Nω-methylserotonin
Total ion chromatograms of A) Nω-methylserotonin standard. B) Fraction 7. A comparison of the product ion tandem mass spectra of Nω-methylserotonin and a compound from fraction 7 eluting at 22 min. The major fragment ion corresponds to the loss of methylamine from the side chain. C) Nω-methylserotonin standard. D) Black cohosh fraction 7.
Figure 5
Figure 5. Nω-methylserotonin can bind to the 5-HT7 receptor
Percent inhibition of 5-HT7 receptor binding with increasing doses of Nω-methylserotonin. IC50 23 pM.
Figure 6
Figure 6. Nω-methylserotonin induces intracellular cAMP
(A) Cyclic AMP intracellular levels of human 5-HT7 transfected HEK293 cells after treatment with Nω-methylserotonin (100 nM). (B) Intracellular cyclic AMP (pmol/mL) as a response of increasing dosage from Nω-methylserotonin mediated through the 5-HT7 receptor. *p < 0.05.
Figure 7
Figure 7. Nω-methylserotonin exhibits SSRI activity
Dose-dependent percent inhibition of selective serotonin reuptake with Nω-methylserotonin. The IC50 value was determined to be 490 nM.

Similar articles

Cited by

References

    1. Mahady GB. Is black cohosh estrogenic? Nutr Rev. 2003;61:183–186. - PubMed
    1. Carpenter JS. State of the science: hot flashes and cancer. Part 2: management and future directions. Oncol Nurs Forum. 2005;32:969–978. - PubMed
    1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–333. - PubMed
    1. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res. 2008;58:8–14. - PubMed
    1. Tesch BJ. Herbs commonly used by women: An evidence-based review. Am J Obstet Gynecol. 2003;188:S44–S55. - PubMed

Publication types